Publication

Article

CURE

Summer 2009
Volume8
Issue 2

Childhood Cancer Survivorship Programs

Childhood cancer survivors need long-term surveillance to keep up with late-term effects, screenings, and other health-related issues.

Childhood cancer survivors need lifelong follow-up care to monitor for secondary cancers, long-term and late effects, and other health-related issues. Below are a list of programs that provide survivorship care to childhood cancer survivors.

http://beyondthecure.org/resources/follow-up-clinics.html.

The National Children’s Cancer Society provides a listing of long-term follow-up clinics for survivors of childhood cancer at

Other Childhood Cancer Survivors Programs:

Children’s Hospital Los Angeles LIFE Program (Long-term Information, Follow-Up and Evaluation)

www.childrenshospitalla.org/site/c.ipINKTOAJsG/b.4347877/k.899B/LIFE_Program.htm

City of Hope Childhood Cancer Survivorship Program

www.cityofhope.org/survivorship

HEROS Clinic at Yale Cancer Center

www.med.yale.edu/pediat/hem_onc/heros/index.html

UCLA’s Jonsson Comprehensive Cancer Center Pediatric Long-Term Follow-Up Program

www.cancer.ucla.edu/Index.aspx?page=222

UCSF Survivors of Childhood Cancer Program

www.ucsfhealth.org/childrens/special/s/100903.html

University of Chicago Comer Children’s Hospital Childhood Cancer Survivors Center

www.uchicagokidshospital.org/specialties/cancer/survivors/index.html

UT Southwestern Medical Center and Children’s Medical Center in Dallas' After the Cancer Experience

www.childrens.com/ace

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of man wearing baseball cap backwards.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
Image of doctor with brown hair.
Image of man with black hair.
Related Content